Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Viruses ; 14(6)2022 06 08.
Article in English | MEDLINE | ID: covidwho-1911618

ABSTRACT

Natural immunity against HIV has been observed in many individuals in the world. Among them, a group of female sex workers enrolled in the Pumwani sex worker cohort remained HIV uninfected for more than 30 years despite high-risk sex work. Many studies have been carried out to understand this natural immunity to HIV in the hope to develop effective vaccines and preventions. This review focuses on two such examples. These studies started from identifying immunogenetic or genetic associations with resistance to HIV acquisition, and followed up with an in-depth investigation to understand the biological relevance of the correlations of protection, and to develop and test novel vaccines and preventions.


Subject(s)
HIV Infections , HIV Seropositivity , HIV-1 , Sex Workers , Female , HIV-1/genetics , Humans , Immunity, Innate
2.
PLoS One ; 16(3): e0247799, 2021.
Article in English | MEDLINE | ID: covidwho-1117486

ABSTRACT

COVID-19 has greatly affected public health and world economy. In this study, we analyzed 129 full-length genomes of SARS-CoV-2 viruses of a Canadian population during early phase of the pandemic. Phylogenetic analysis revealed three major paths of transmission of SARS-CoV-2 viruses into Canada. Twenty-one substitutions that have frequencies greater than 3% of viral population were identified. Analysis of these substitutions indicated that P1427I (ORF1b), Y1464C (ORF1b), and Q57H (ORF3a) might affect functions of the corresponding SARS-CoV-2 encoded proteins. Additionally, we found the evidence of positive selection on the ORF3a and codon 614 of Spike protein, suggesting the viral components responsible for host entry and activation of inflammation response were targeted by host immune responses. The study showed genomic variation and evolution of SARS-CoV-2 in a Canadian population. These information may help develop preventive strategies and be used for further study of SARS-CoV-2 pathogenesis and therapeutics development.


Subject(s)
COVID-19/virology , Genome, Viral , SARS-CoV-2/genetics , COVID-19/epidemiology , Canada/epidemiology , Evolution, Molecular , Genetic Variation , Humans , Phylogeny , SARS-CoV-2/isolation & purification , Spike Glycoprotein, Coronavirus/genetics , Viral Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL